FDA approved first RDT for use in the U.S., BinaxNOW Malaria

On June 13, 2007, the FDA approved the first rapid diagnostic test (RDT) for use in the United States, the Binax NOW Malaria. This RDT is approved for use by hospital/commercial laboratories, not by individual clinicians or by patients themselves. It is recommended that all RDTs are followed by microscopy to confirm the results and, if positive, to quantify the proportion of red blood cells that are infected. This video provides guidance regarding the test procedure and results interpretation.

Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=b039fe9f6b21deabc5bc9acfc111bf5a20140513105948265

Видео FDA approved first RDT for use in the U.S., BinaxNOW Malaria канала Centers for Disease Control and Prevention (CDC)